1. Natriuretic peptides: biomarkers for atrial fibrillation management

   • Alireza Sepehri Shamloo
   • Andreas Bollmann
   • Arash Arya

   Review 30 January 2020 Pages: 957 - 966

   

2. Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study

   • Carlo Mario Lombardi
   • João Pedro Ferreira
   • Marco Metra

   Original Paper 29 January 2020 Pages: 967 - 977

   

3. Amplified P-wave duration predicts new-onset atrial fibrillation in patients with heart failure with preserved ejection fraction

   • Björn Müller-Edenborn
   • Jan Minners
   • Amir Jadidi

   Original Paper 21 December 2019 Pages: 978 - 987

   

4. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging

   • Yoshinori Kagioka
   • Masakazu Yasuda
   • Yoshitaka Iwanaga

   Original Paper 23 December 2019 Pages: 988 - 998

   

5. High density mapping and catheter ablation of atrial tachycardias in adults with congenital heart disease

   • Ulrich Krause
   • Matthias J. Müller
   • Thomas Paul

   Original Paper 02 January 2020 Pages: 999 - 1007

   

6. Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism

   • Lukas Hobohm
   • Cecilia Becattini
   • Mareike Lankeit

   Original Paper Open access 06 February 2020 Pages: 1008 - 1017

   

7. Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial

   • Monika Kozieł
   • Naab Al-Saady
   • Gregory Y. H. Lip

   Original Paper Open access 08 January 2020 Pages: 1018 - 1024

   

8. Outcomes in patients with dual antegrade conduction in the atrioventricular node: insights from a multicentre observational study

   • Jens Hartmann
   • Christiane Jungen
   • Christian Meyer

   Original Paper Open access 30 January 2020 Pages: 1025 - 1034

   

9. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD)

   • Robert Claus
   • Dominik Berliner
   • Michael S. Balzer

   Original Paper Open access 30 January 2020 Pages: 1035 - 1047

   

10. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction

    • Jozine M. ter Maaten
    • Pieter Martens
    • Wilfried Mullens

    Original Paper Open access 30 January 2020 Pages: 1048 - 1059

    

11. Association of estimated plasma volume status with hemodynamic and echocardiographic parameters

    • Masatake Kobayashi
    • Olivier Huttin
    • Nicolas Girerd

    Original Paper 31 January 2020 Pages: 1060 - 1069

    

12. Pulmonary vein isolation treats symptomatic AF in a patient with Lamin A/C mutation: case report and review of the literature

    • Ann-Kathrin Rahm
    • Patrick Lugenbiel
    • Eberhard Scholz

    Letter to the Editors Open access 06 March 2020 Pages: 1070 - 1075

    

13. Simultaneous two-sided endocarditis: cardiac resynchronization leads and left atrial appendage occluder

    • Maximilian von Roeder
    • David Holzhey
    • Holger Thiele

    Letter to the Editors Open access 05 March 2020 Pages: 1076 - 1077